Burkehill Global Management, LP Biomea Fusion, Inc. Transaction History
Burkehill Global Management, LP
- $1.76 Trillion
- Q3 2025
Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
80Shares Held
20MCall Options Held
1.07MPut Options Held
336K-
Cormorant Asset Management, LP Boston, MA3.57MShares$4.57 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.97MShares$3.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$2.62 Million0.94% of portfolio
-
Heights Capital Management, Inc San Francisco, CA1.44MShares$1.84 Million0.8% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $37.5M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...